https://doi.org/10.1002/ajmg.a.36887
T
Tarja Linnankivi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
4.6K
Citations
31
h-index
42
i10-index
Tarja Linnankivi is an academic researcher from University of Helsinki. The author has contributed to research in topics: Genetics and Neurodevelopmental Disorders & Genomics and Rare Diseases & Epilepsy research and treatment. The author has an h-index of 31, co-authored 62 publications.
ORCID: 0000-0001-9190-2218Papers by this author
worksCharacterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
2015 · American Journal of Medical Genetics Part A · 601 citations
De novo variants in neurodevelopmental disorders with epilepsy
2018 · Nature Genetics · 312 citations
https://doi.org/10.1038/s41588-018-0143-7
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
2015 · Nature Genetics · 265 citations
https://doi.org/10.1038/ng.3239
<i>GRIN2B</i> encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects
2017 · Journal of Medical Genetics · 249 citations
https://doi.org/10.1136/jmedgenet-2016-104509
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture
2023 · Nature Genetics · 189 citations
https://doi.org/10.1038/s41588-023-01485-w
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
2018 · Epilepsia · 147 citations
https://doi.org/10.1111/epi.13986
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat